Literature DB >> 10936820

Real-time transmission of full-motion echocardiography over a high-speed data network: impact of data rate and network quality of service.

M L Main1, D Foltz, M S Firstenberg, E Bobinsky, D Bailey, B Frantz, D Pleva, M Baldizzi, D P Meyers, K Jones, M C Spence, K Freeman, A Morehead, J D Thomas.   

Abstract

UNLABELLED: With high-resolution network transmission required for telemedicine, education, and guided-image acquisition, the impact of errors and transmission rates on image quality needs evaluation.
METHODS: We transmitted clinical echocardiograms from 2 National Aeronautics and Space Administration (NASA) research centers with the use of Motion Picture Expert Group-2 (MPEG-2) encoding and asynchronous transmission mode (ATM) network protocol over the NASA Research and Education Network. Data rates and network quality (cell losses [CLR], errors [CER], and delay variability [CVD]) were altered and image quality was judged.
RESULTS: At speeds of 3 to 5 megabits per second (Mbps), digital images were superior to those on videotape; at 2 Mbps, images were equivalent. Increasing CLR caused occasional, brief pauses. Extreme CER and CDV increases still yielded high-quality images.
CONCLUSIONS: Real-time echocardiographic acquisition, guidance, and transmission is feasible with the use of MPEG-2 and ATM with broadcast quality seen above 3 Mbps, even with severe network quality degradation. These techniques can be applied to telemedicine and used for planned echocardiography aboard the International Space Station.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; Non-NASA Center

Mesh:

Year:  2000        PMID: 10936820     DOI: 10.1067/mje.2000.106075

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  2 in total

1.  Objective video quality measure for application to tele-echocardiography.

Authors:  Peter Thomas Moore; Neil O'Hare; Kevin P Walsh; Neil Ward; Niamh Conlon
Journal:  Med Biol Eng Comput       Date:  2008-07-10       Impact factor: 2.602

2.  Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine.

Authors:  Patrick A Gladding; Andrew Cave; Mehran Zareian; Kevin Smith; Jagir Hussan; Peter Hunter; Folarin Erogbogbo; Zoraida Aguilar; David S Martin; Eugene Chan; Margie L Homer; Abhijit V Shevade; Mohammad Kassemi; James D Thomas; Todd T Schlegel
Journal:  J Pers Med       Date:  2013-08-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.